Home> Trial Details

Information Clinical trials have complex eligibility criteria.
Always talk to your clinician about you’re interest in participating in a trial.Learn why

Optimise reading forHealth Professionals Patients

RecruitingLast updated:15 August 2023

BELLA: This Phase II trial is trying to determine how effective using a combination of cancer drugs (carboplatin, gemcitabine, bevacizumab and atezolizumab) is in people with early relapsed triple negative breast cancerA Single Arm Phase II Trial Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Early Relapsing Metastatic Triple Negative Breast Cancer

Clinical summary Eligibilty Participating hospital Support

Clinical summary

Summary

This trial as one experimental arm. Participants will receive Atezolizumab 1200 mg Day 1 of each 21 day cycle intravenously, Bevacizumab 15 mg/kg Day 1 of each 21 day cycle intravenously, Gemcitabine 1000 mg/m2 Day 1 and 8 of each 21 day cycle intravenously, and Carboplatin AUC 5 Day 1 of each 21 day cycle intravenously.

Treatment Type

Radiotherapy

Age

People 18 - 100

Phase

Trial Acronym

BELLA

More information

Trial Identifiers

Use the hyperlinks, where available to access additional clinical trial information.

NCT04739670
19/002; BELLA V1.0

Commercial Sponsor

Peter MacCallum Cancer Centre

Scientific Title

A Single Arm Phase II Trial Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Early Relapsing Metastatic Triple Negative Breast Cancer

Share with email

Print this page

Download brochure

Eligibility

Inclusion

You have certain types of non-cancer medical conditions.
You have had certain treatments, surgical procedures or drugs.

Exclusion

You have been diagnosed with cancer, but have not received any treatment.
You have had treatment but your cancer has gotten worse or has not responded to the treatment you have been given.
You have had treatment, but your cancer has come back.
Your cancer has not spread to other parts of the body.
Your cancer has spread to other parts of the body.

Clinical trials have complex eligibility criteria.

Ask your doctor if this trial could be right for you.

Participating hospitals

Recruiting hospitals

Information Tell us if you find this trial availability is not accurate.Report inaccuracy